Mejhert et al. 19 has identified SEMA3C as an adipokine, based on the findings that it is primarily secreted from subcutaneous adipose tissues and its expression is regulated by the degree of obesity, fat-cell morphology, and weight changes. The gene discussed is SEMA3C; the disease is obesity disorder.